查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1454232

全球药物滥用治疗市场：按类型、按治疗类型、按年龄层、按治疗环境、按地区

Global Substance Abuse Treatment Market, By Type, By Treatment Type, By Age Group, By Treatment Setting, By Geography
出版日期: | 出版商: Coherent Market Insights | 英文 180 Pages | 商品交期: 2-3个工作天内

价格
简介目录

2023年全球药物滥用治疗市场价值为118亿美元，预计到2031年将达228亿美元，2024年至2031年复合年增长率为8.6%。

报告范围 报告详情
基准年 2023年 2023/2024年市场规模 118亿美元
实际资料 2019-2023 预测期 2024-2031
预测期2023/2024~2030/2031年复合成长率： 8.60% 2030/2031价值预测 228亿美元
图 1. 2023 年全球市场占有率(%)（按地区）
全球药物滥用治疗市场-IMG1

药物滥用治疗是指旨在控制药物依赖并支持长期清醒和康復的计划和活动。药物滥用障碍，也称为成瘾，涉及强迫性或无法控制地使用有害和成瘾物质，儘管它们有负面影响。常见的滥用物质包括酒精、鸦片类药物、大麻、古柯碱和兴奋剂。药物滥用障碍的主要症状包括无法减少摄取量、产生渴望以及在不使用药物时出现戒断症状。患有成瘾的人经常会出现自我控制力下降、社交问题、危险使用，有时还会出现身体依赖。药物滥用治疗旨在透过治疗性介入、咨询、药物治疗和社区支持计划来解决成瘾的生物、心理、社会和行为方面的问题。全球药物滥用率不断上升，刺激了对有效治疗方案的需求。

市场动态：

全球药物滥用治疗市场的推动因素包括药物滥用疾病盛行率的上升、对治疗有效性的认识不断提高、有利的监管和报销政策以及新型药物辅助治疗产品的推出。然而，与成瘾相关的社会耻辱、低收入地区缺乏治疗设施以及违规治疗通讯协定等问题可能会抑制市场成长。开拓的数位治疗解决方案、综合护理模式、针对成瘾的针对性治疗以及向新兴市场的扩张为市场参与者提供了关键机会。从地区来看，北美因其先进的医疗基础设施和意识而占据市场主导地位。然而，亚太地区预计在预测期内将出现良好的成长。

本研究的主要特点

  • 该报告对全球药物滥用治疗市场进行了详细分析，并提供了以2023年为基准年的预测期（2024-2031年）的市场规模和年复合成长率（CAGR%）。
  • 它还说明了各个细分市场的潜在收益成长机会，并为该市场提供了一系列有吸引力的投资提案。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要见解。
  • 它根据公司亮点、产品系列、主要亮点、财务表现和策略等参数，介绍了全球药物滥用治疗市场的主要企业。
  • 该报告的见解使负责人和公司经营团队能够就未来的产品发布、类型升级、市场扩张和行销策略做出明智的决策。
  • 全球药物滥用治疗市场报告迎合了该行业的各种相关人员，如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 透过用于分析全球药物滥用治疗市场的各种策略矩阵，将促进相关人员的决策。

目录

第一章 研究目的与前提

  • 研究目标
  • 先决条件
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map（COM）

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素：
  • 药物和酒精消费量增加
  • 政府和非政府组织的支持扩大
    • 抑制因素
  • 与药物成瘾相关的社会耻辱
  • 缺乏足够的復健设施
    • 机会
  • 新兴国家尚未开发的市场
  • 公司市场占有率分析
  • 主要亮点
  • 市场趋势
  • PEST分析
  • 波特的分析
  • 最近的产品核准/发布
  • 合併、收购和合作

第四章全球药物滥用治疗市场－冠状病毒 (COVID-19) 大流行的影响

  • 新型冠状病毒感染疾病（COVID-19）的流行病学
  • 供需面分析
  • 经济影响

第五章全球药物滥用治疗市场，依类型，2019-2031

  • 酒精
  • 阿片类药物（海洛因、处方止痛药等）
  • 烟草/尼古丁
  • 古柯碱
  • 大麻
  • 甲基安非他命
  • 其他非法药物（苯二氮平类药物等）

第六章全球药物滥用治疗市场，依治疗类型，2019-2031

  • 阿片类药物
  • 美沙酮
  • Buprenornhine
  • 缓释性纳曲酮
  • 洛非西定
  • 尼古丁
  • 尼古丁替代疗法（以贴片、吸入器或口香糖形式提供）
  • 安非他酮
  • Varenicline
  • 酒精
  • 纳曲酮
  • Disulfiram
  • Acamprosate
  • 烟草
  • 可乐定
  • 去甲替林
  • 其他（托吡酯、Modafinil等）

第七章 全球药物滥用治疗市场，依年龄组，2019-2031

  • 青年
  • 成人
  • 老年人

第 8 章 全球药物滥用治疗市场（依治疗环境），2019-2031 年

  • 门诊治疗
  • 门诊
  • 私人诊所
  • 住院治疗
  • 復健中心
  • 医院
  • 住宅治疗设施
  • 戒毒中心

第九章全球药物滥用治疗市场，依地区划分，2019-2031

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 德国
  • 英国
  • 西班牙
  • 法国
  • 义大利
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国
  • ASEAN
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 阿根廷
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 海湾合作委员会国家
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第10章竞争格局

  • 公司简介
    • Indivior PLC
    • Pfizer, Inc.
    • Johnson &Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players

第11章 章节

  • 参考
  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI6671

Global substance abuse treatment market was valued US$ 11.8 Bn in 2023 and is expected to reach US$ 22.8 Bn by 2031 exhibiting a compound annual growth rate (CAGR) of 8.6% from 2024 to 2031.

Report Coverage Report Details
Base Year: 2023 Market Size in 2023/2024: US$ 11.8 Bn
Historical Data for: 2019 to 2023 Forecast Period: 2024 - 2031
Forecast Period 2023/2024 to 2030/2031 CAGR: 8.60% 2030/2031 Value Projection: US$ 22.8 Bn
Figure 1. Global Substance Abuse Treatment Market Share (%), By Region, 2023
Global Substance Abuse Treatment Market - IMG1

Substance abuse treatment refers to programs and activities that are aimed at managing substance dependence and support long-term sobriety and recovery. Substance abuse disorder which is also known as addiction, involves the compulsive or uncontrollable use of harmful and addictive substances despite their negative impact. Common substances of abuse include alcohol, opioids, cannabis, cocaine, and methamphetamines. Some key signs of substance abuse disorder include the inability to reduce intake, experiencing cravings, and having withdrawal symptoms when not using. Those suffering from addiction often experience impaired control, social problems, risky use, and sometimes even physical dependence. Substance abuse treatment aims to address the biological, psychological, social, and behavioral aspects of addiction through therapeutic interventions, counseling, medication, and community support programs. The rise in substance abuse rates globally is fueling demand for effective treatment options.

Market Dynamics:

Global substance abuse treatment market is driven by the rising prevalence of substance abuse disorders, increasing awareness regarding treatment availability, favorable regulations and reimbursement policies, and the launch of novel medication-assisted treatment products. However, the market growth can be restrained by social stigmas that are associated with addiction, lack of access to treatment facilities in low-income regions, and non-compliance issues with treatment protocols. The development of digital therapeutic solutions, integrated care models, targeted therapies for specific addictions, and expansion to emerging markets present key opportunities for the market players. Geographically, North America dominates the market due to advanced healthcare infrastructure and awareness. However, the Asia Pacific region is expected to offer lucrative growth prospects during the forecast period.

Key Features of the Study:

  • This report provides an in-depth analysis of the global substance abuse treatment market, and provides market size (US$ Bn) and compound annual growth rate (CAGR %) for the forecast period (2024-2031), considering 2023 as the base year.
  • It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global substance abuse treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Indivior PLC, Pfizer, Inc., Johnson & Johnson Inc., Alkermes., Mallinckrodt Pharmaceuticals, Teva Pharmaceuticals, Inc., Par Pharmaceutical, Inc., USWM, LLC, Valeant Pharmaceuticals, Greenyard Pharmaceutical Ltd. Cipla Health Limited. Perrigo, Haleon Group of Companies, Ventus Medical, Glenmark and other prominent players.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • Global substance abuse treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global substance abuse treatment market.

Detailed Segmentation:

  • Global Substance Abuse Treatment Market, By Type
    • Alcohol
    • Opioids (e.g., heroin, prescription painkillers)
    • Tobacco/nicotine
    • Cocaine
    • Marijuana
    • Methamphetamines
    • Other illicit drugs (Benzodiazepines, etc.)
  • Global Substance Abuse Treatment Market, By Treatment Type
    • Opioid
    • Methadone
    • Buprenorphine
    • Extended-release naltrexone
    • Lofexidine
    • Nicotine
    • Nicotine replacement therapies (available as a patch, inhaler, or gum)
    • Bupropion
    • Varenicline
    • Alcohol
    • Naltrexone
    • Disulfiram
    • Acamprosate
    • Tobacco
    • Clonidine
    • Nortriptyline
    • Others (Topiramate, Modafinil, etc.)
  • Global Substance Abuse Treatment Market, By Age Group
    • Adolescents
    • Adults
    • Geriatric
  • Global Substance Abuse Treatment Market, By Treatment Setting
    • Outpatient Treatment
    • Outpatient Clinics
    • Private Practices
    • Inpatient Treatment
    • Rehabilitation Centers
    • Hospitals
    • Residential Treatment Facilities
    • Detoxification Centers
  • Global Substance Abuse Treatment Market, By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Top Companies in the Global Substance Abuse Treatment Market:
    • Indivior PLC
    • Pfizer, Inc.
    • Johnson & Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snippet, By Type
    • Market Snippet, By Treatment Type
    • Market Snippet, By Age Group
    • Market Snippet, By Treatment Setting
    • Market Snippet, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers:
  • Increasing consumption of drugs and alcohol
  • Growing support from government and NGOs
    • Restraints
  • Social stigma associated with substance dependence
  • Lack of adequate rehabilitation facilities
    • Opportunities
  • Untapped markets in developing countries
  • Company Market Share Analysis
  • Key Highlights
  • Market Trends
  • PEST Analysis
  • PORTER's Analysis
  • Recent Product Approvals/Launches
  • Mergers, Acquisitions, and Collaborations

4. Global Substance Abuse Treatment Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Global Substance Abuse Treatment Market, By Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Alcohol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Opioids (e.g., heroin, prescription painkillers)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Tobacco/nicotine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Cocaine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Marijuana
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Methamphetamines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Other illicit drugs (Benzodiazepines, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

6. Global Substance Abuse Treatment Market, By Treatment Type, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Opioid
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Methadone
  • Buprenorphine
  • Extended-release naltrexone
  • Lofexidine
  • Nicotine
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Nicotine replacement therapies (available as a patch, inhaler, or gum)
  • Bupropion
  • Varenicline
  • Alcohol
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Naltrexone
  • Disulfiram
  • Acamprosate
  • Tobacco
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Clonidine
  • Nortriptyline
  • Others (Topiramate, Modafinil, etc.)
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

7. Global Substance Abuse Treatment Market, By Age Group, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Adolescents
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Adults
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Geriatric
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

8. Global Substance Abuse Treatment Market, By Treatment Setting, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, 2019 - 2031
    • Segment Trends
  • Outpatient Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Outpatient Clinics
  • Private Practices
  • Inpatient Treatment
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Rehabilitation Centers
  • Hospitals
  • Residential Treatment Facilities
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)
  • Detoxification Centers
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2019-2031,(US$ Bn)

9. Global Substance Abuse Treatment Market, By Region, 2019-2031, (US$ Bn)

  • Introduction
    • Market Share Analysis, By Region, 2024 and 2031 (%)
    • Y-o-Y Growth Analysis, For Region, 2019 - 2031
    • Country Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Germany
  • U.K.
  • Spain
  • France
  • Italy
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • Brazil
  • Argentina
  • Mexico
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2019-2031,(US$ Bn)
  • GCC Countries
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Treatment Setting, 2019-2031,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2019-2031,(US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

10. Competitive Landscape

  • Company Profile
    • Indivior PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Pfizer, Inc.
    • Johnson & Johnson Inc.
    • Mallinckrodt Pharmaceuticals
    • Teva Pharmaceuticals, Inc.
    • Par Pharmaceutical, Inc.
    • USWM, LLC
    • Valeant Pharmaceuticals
    • Greenyard Pharmaceutical Ltd
    • Cipla Health Limited
    • Perrigo
    • Haleon Group of Companies
    • Ventus Medical
    • Glenmark
    • Other Prominent Players
  • Analyst Views

11. Section

  • References
  • Research Methodology
  • About us